Farnesol (3a) is the precursor to the irregular C12 terpenoid (4S, 4aS, 8aS)‐1,2,3,4,4a,5,8,8a‐octahydro‐4,8a‐dimethylnaphthalen‐4a‐ol (= dehydrogeosmin; 1). The irregular C‐backbone originates from the oxidative removal of a C3 side chain from a C15 eudesmane‐type intermediate (Scheme 2). The bicyclic C‐framework is assembled by a formal addition of H2O across the endocyclic double bonds of a monocyclic germacradiene‐type precursor. The biosynthetic pathway follows from administration of the deuteriated farnesols 3b–e to flower heads of the cactaceae Rebutia marsoneri Werd. and mass‐spectroscopic analysis of the collected volatiles.
No takes yet. Share an insight, caveat, or question.
Huber et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: